These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1575895)

  • 1. T cells and tumors.
    Maas RA; Dullens HF; Den Otter W
    Immunol Today; 1992 Feb; 13(2):78-9. PubMed ID: 1575895
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunotherapy.
    Manson LA
    Immunol Today; 1989 Feb; 10(2):36. PubMed ID: 2787650
    [No Abstract]   [Full Text] [Related]  

  • 3. Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
    Manson LA
    Immunol Today; 1991 Oct; 12(10):352-5. PubMed ID: 1720318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.
    Melief CJ; Kast WM
    Semin Cancer Biol; 1991 Oct; 2(5):347-54. PubMed ID: 1773050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic T-cell immune response against melanoma antigens].
    Ayyoub M
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte responses to spontaneous tumors: immunogenicity dependent on the recognition of processed tumor antigens.
    Bellgrau D; Zöller M
    J Immunol; 1983 May; 130(5):2005-7. PubMed ID: 6403615
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
    Finn OJ
    Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological analysis of melanoma-specific antigen].
    Wakabayashi S; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(11):1145-51. PubMed ID: 3879298
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanoma and immunity.
    Rheins LA; Nordlund JJ
    Immunol Ser; 1989; 46():769-87. PubMed ID: 2484957
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor-regression antigens in melanoma.
    Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
    Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular engineering of the antitumor immune response.
    Pardoll DM; Golumbek P; Levitsky H; Jaffee L
    Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
    Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
    J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
    Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
    Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 gene transduction in malignant cells: applications in cancer containment.
    Roth C; Mir L; Cressent M; Quintin-Colonna F; Ley V; Fradelizi D; Kourilsky P
    Bone Marrow Transplant; 1992; 9 Suppl 1():174-5. PubMed ID: 1504663
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer. Cancer immunotherapy is more than a numbers game.
    Offringa R
    Science; 2006 Oct; 314(5796):68-9. PubMed ID: 17023641
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
    Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ
    Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.
    Scott CF; Blättler WA; Lambert JM; Kalish RS; Morimoto C; Schlossman SF
    J Clin Invest; 1988 May; 81(5):1427-33. PubMed ID: 2966815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic activity in murine and human systems. A review.
    Lattime EC
    Year Immunol; 1986; 2():261-6. PubMed ID: 3554823
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagen-induced antigenic variants of tumor cells.
    Boon T; Van Pel A; De Plaen E; Vessière F
    Symp Fundam Cancer Res; 1986; 38():139-48. PubMed ID: 3489258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.